Rekor Systems Provides Guidance on Financial Results and Updates on Operational and Management Realignments
March 17, 2025 07:30 ET
|
Rekor Systems
COLUMBIA, Md., March 17, 2025 (GLOBE NEWSWIRE) -- Rekor Systems, Inc. (NASDAQ: REKR), a global leader in roadway intelligence, today provided insights into its preliminary year-end 2024 results and...
ProKidney Reports Full Year 2024 Financial Results and Business Highlights
March 17, 2025 07:30 ET
|
ProKidney
Significant progress was made in 2024, including refining the Phase 3 program to accelerate rilparencel’s path to market in the U.S., the release of positive Phase 2 data, restarting manufacturing,...
Open Lending Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
March 17, 2025 07:30 ET
|
Open Lending Corporation
AUSTIN, Texas, March 17, 2025 (GLOBE NEWSWIRE) -- Open Lending Corporation (NASDAQ: LPRO) (“Open Lending” or the “Company”) today announced that it is postponing its earnings release and conference...
Aptose Biosciences Meets Nasdaq Minimum Bid Price Compliance
March 17, 2025 07:30 ET
|
Aptose Biosciences, Inc.
Aptose Biosciences Meets Nasdaq Minimum Bid Price Compliance
Creative Realities Announces Reflect Settlement Agreement
March 17, 2025 07:30 ET
|
Creative Realities
LOUISVILLE, Ky., March 17, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage and AdTech...
Digi Power X Announces Nasdaq Ticker Symbol Change to DGXX
March 17, 2025 07:30 ET
|
Digi Power X Inc.
MIAMI, March 17, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGHI, DGXX / TSXV: DGX), an innovative energy infrastructure company that develops cutting-edge...
IREN Secures 2.75GW for Data Centers in West Texas with New 600MW Grid Connection Agreement
March 17, 2025 07:20 ET
|
IREN
SYDNEY, March 17, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN”), today announced the signing of a 600MW grid connection agreement for Sweetwater 2,...
SAIC Announces Fourth Quarter and Full Fiscal Year 2025 Results
March 17, 2025 07:05 ET
|
SAIC, Inc.
Q4 FY25 revenues of $1.84 billion, 5.8% organic growth(1); FY25 revenues of $7.48 billion, 3.1% organic growth(1); organic growth adjusted for divestituresQ4 FY25 net income of $98 million, adjusted...
Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief Medical Officer
March 17, 2025 07:05 ET
|
Zenas BioPharma
–Dr. von Moltke brings over 30 years of deep drug development experience and a proven track record of clinical and regulatory success at both large and emerging global biopharmaceutical companies– ...
Travere Therapeutics Submits sNDA to FDA for Approval of FILSPARI® (sparsentan) for the Treatment of FSGS
March 17, 2025 07:01 ET
|
Travere Therapeutics, Inc.
Travere announces sNDA submission to FDA based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGS, a rare kidney condition.